49 results on '"Coleman, Michael"'
Search Results
2. Data-driven, connectome-wide analysis identifies psychosis-specific brain correlates of fear and anxiety
- Author
-
Feola, Brandee, Beermann, Adam, Manzanarez Felix, Karlos, Coleman, Michael, Bouix, Sylvain, Holt, Daphne J., Lewandowski, Kathryn E., Öngür, Dost, Breier, Alan, Shenton, Martha E., Heckers, Stephan, Brady, Jr, Roscoe O., Blackford, Jennifer Urbano, and Ward, Heather Burrell
- Published
- 2024
- Full Text
- View/download PDF
3. Programmed axon death: a promising target for treating retinal and optic nerve disorders
- Author
-
Loreto, Andrea, Merlini, Elisa, and Coleman, Michael P.
- Published
- 2024
- Full Text
- View/download PDF
4. Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project.
- Author
-
Su, Yi, Protas, Hillary, Luo, Ji, Chen, Kewei, Alosco, Michael, Adler, Charles, Balcer, Laura, Bernick, Charles, Au, Rhoda, Banks, Sarah, Barr, William, Coleman, Michael, Dodick, David, Katz, Douglas, Marek, Kenneth, McClean, Michael, McKee, Ann, Mez, Jesse, Daneshvar, Daniel, Palmisano, Joseph, Peskind, Elaine, Turner, Robert, Wethe, Jennifer, Johnson, Keith, Tripodis, Yorghos, Cummings, Jeffrey, Shenton, Martha, Stern, Robert, Reiman, Eric, and Rabinovici, Gil
- Subjects
CTE ,PET ,Tau ,flortaucipir ,football ,Male ,Humans ,Middle Aged ,Chronic Traumatic Encephalopathy ,Football ,tau Proteins ,Positron-Emission Tomography ,Brain Injuries ,Traumatic ,Carbolines - Abstract
INTRODUCTION: Tau is a key pathology in chronic traumatic encephalopathy (CTE). Here, we report our findings in tau positron emission tomography (PET) measurements from the DIAGNOSE CTE Research Project. METHOD: We compare flortaucipir PET measures from 104 former professional players (PRO), 58 former college football players (COL), and 56 same-age men without exposure to repetitive head impacts (RHI) or traumatic brain injury (unexposed [UE]); characterize their associations with RHI exposure; and compare players who did or did not meet diagnostic criteria for traumatic encephalopathy syndrome (TES). RESULTS: Significantly elevated flortaucipir uptake was observed in former football players (PRO+COL) in prespecified regions (p
- Published
- 2024
5. Differential effects of leptin on energy metabolism in murine cell models of metastatic triple negative breast cancer
- Author
-
Yum, Chaehyun, Andolino, Chaylen, Layosa, Marjorie Anne, Coleman, Michael, Hursting, Stephen D., and Teegarden, Dorothy
- Published
- 2024
- Full Text
- View/download PDF
6. Aggravating mechanisms from COVID-19
- Author
-
Lee, Jong Hoon, Sergi, Consolato, Kast, Richard E., Kanwar, Badar A., Bourbeau, Jean, Oh, Sangsuk, Sohn, Mun-Gi, Lee, Chul Joong, and Coleman, Michael D.
- Published
- 2024
- Full Text
- View/download PDF
7. Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production
- Author
-
Tribble, James R., Jöe, Melissa, Varricchio, Carmine, Otmani, Amin, Canovai, Alessio, Habchi, Baninia, Daskalakis, Evangelia, Chaleckis, Romanas, Loreto, Andrea, Gilley, Jonathan, Wheelock, Craig E., Jóhannesson, Gauti, Wong, Raymond C. B., Coleman, Michael P., Brancale, Andrea, and Williams, Pete A.
- Published
- 2024
- Full Text
- View/download PDF
8. NMNAT2 is a druggable target to drive neuronal NAD production
- Author
-
Tribble, James R., Jöe, Melissa, Varricchio, Carmine, Otmani, Amin, Canovai, Alessio, Habchi, Baninia, Daskalakis, Evangelia, Chaleckis, Romanas, Loreto, Andrea, Gilley, Jonathan, Wheelock, Craig E., Jóhannesson, Gauti, Wong, Raymond C. B., Coleman, Michael P., Brancale, Andrea, and Williams, Pete A.
- Published
- 2024
- Full Text
- View/download PDF
9. Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression
- Author
-
Coleman, Michael F., Cotul, Eylem Kulkoyluoglu, Pfeil, Alexander J., Devericks, Emily N., Safdar, Muhammad H., Monteiro, Marvis, Chen, Hao, Ho, Alyssa N., Attaar, Numair, Malian, Hannah M., Kiesel, Violet A., Ramos, Alexis, Smith, Matthew, Panchal, Heena, Mailloux, Adam, Teegarden, Dorothy, Hursting, Stephen D., and Wendt, Michael K.
- Published
- 2024
- Full Text
- View/download PDF
10. Subcutaneous injection of adipose stromal cell-secretome improves renal function and reduces inflammation in established acute kidney injury
- Author
-
Ullah, Md Mahbub, Collett, Jason A., Monroe, Jacob C., Traktuev, Dmitry, Coleman, Michael, March, Keith L., and Basile, David P.
- Published
- 2024
- Full Text
- View/download PDF
11. Effect of indoor residual spraying on sandfly abundance and incidence of visceral leishmaniasis in India, 2016–22: an interrupted time-series analysis and modelling study
- Author
-
Coffeng, Luc E, de Vlas, Sake J, Singh, Rudra Pratap, James, Ananthu, Bindroo, Joy, Sharma, Niteen K, Ali, Asgar, Singh, Chandramani, Sharma, Sadhana, and Coleman, Michael
- Published
- 2024
- Full Text
- View/download PDF
12. Isolation of Distinct Networks Driving Action and Cognition in Psychomotor Processes
- Author
-
Moussa-Tooks, Alexandra B., Beermann, Adam, Manzanarez Felix, Karlos, Coleman, Michael, Bouix, Sylvain, Holt, Daphne, Lewandowski, Kathryn E., Öngür, Dost, Breier, Alan, Shenton, Martha E., Heckers, Stephan, Walther, Sebastian, Brady, Roscoe O., Jr., and Ward, Heather Burrell
- Published
- 2024
- Full Text
- View/download PDF
13. Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer
- Author
-
Zhao, Ziyi, Wang, Jiandong, Kong, Weimin, Fang, Ziwei, Coleman, Michael F., Milne, Ginger L., Burkett, Wesley C., Newton, Meredith A., Lara, Olivia, Lee, Douglas, Deng, Boer, Shen, Xiaochang, Suo, Hongyan, Sun, Wenchuan, Hursting, Stephen D., Zhou, Chunxiao, and Bae-Jump, Victoria L.
- Published
- 2024
- Full Text
- View/download PDF
14. Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment
- Author
-
Hunt, Elizabeth G., Hurst, Katie E., Riesenberg, Brian P., Kennedy, Andrew S., Gandy, Evelyn J., Andrews, Alex M., del Mar Alicea Pauneto, Coral, Ball, Lauren E., Wallace, Emily D., Gao, Peng, Meier, Jeremy, Serody, Jonathan S., Coleman, Michael F., and Thaxton, Jessica E.
- Published
- 2024
- Full Text
- View/download PDF
15. AuNPs with Cynara scolymus leaf extracts rescue arsenic-induced neurobehavioral deficits and hippocampal tissue toxicity in Balb/c mice through D1R and D2R activation
- Author
-
Cicek, Betul, Hacimuftuoglu, Ahmet, Yeni, Yesim, Kuzucu, Mehmet, Genc, Sidika, Cetin, Ahmet, Yavuz, Emre, Danısman, Betul, Levent, Akin, Ozdokur, Kemal Volkan, Kantarcı, Mecit, Docea, Anca Oana, Siokas, Vasileios, Tsarouhas, Konstantinos, Coleman, Michael D., Tsatsakis, Aristidis, and Taghizadehghalehjoughi, Ali
- Published
- 2024
- Full Text
- View/download PDF
16. Quality and Agreement With Scientific Consensus of ChatGPT Information Regarding Corneal Transplantation and Fuchs Dystrophy
- Author
-
Barclay, Kayson S., You, Jane Y., Coleman, Michael J., Mathews, Priya M., Ray, Vincent L., Riaz, Kamran M., De Rojas, Joaquin O., Wang, Aaron S., Watson, Shelly H., Koo, Ellen H., and Eghrari, Allen O.
- Published
- 2024
- Full Text
- View/download PDF
17. Brain morphometry in former American football players: findings from the DIAGNOSE CTE research project.
- Author
-
Arciniega, Hector, Baucom, Zachary H, Tuz-Zahra, Fatima, Tripodis, Yorghos, John, Omar, Carrington, Holly, Kim, Nicholas, Knyazhanskaya, Evdokiya E, Jung, Leonard B, Breedlove, Katherine, Wiegand, Tim L T, Daneshvar, Daniel H, Rushmore, R Jarrett, Billah, Tashrif, Pasternak, Ofer, Coleman, Michael J, Adler, Charles H, Bernick, Charles, Balcer, Laura J, and Alosco, Michael L
- Subjects
CHRONIC traumatic encephalopathy ,FOOTBALL ,HEAD injuries ,SYMPTOMS ,MAGNETIC resonance imaging - Abstract
Exposure to repetitive head impacts in contact sports is associated with neurodegenerative disorders including chronic traumatic encephalopathy (CTE), which currently can be diagnosed only at post-mortem. American football players are at higher risk of developing CTE given their exposure to repetitive head impacts. One promising approach for diagnosing CTE in vivo is to explore known neuropathological abnormalities at post-mortem in living individuals using structural MRI. MRI brain morphometry was evaluated in 170 male former American football players ages 45–74 years (n = 114 professional; n = 56 college) and 54 same-age unexposed asymptomatic male controls (n = 54, age range 45–74). Cortical thickness and volume of regions of interest were selected based on established CTE pathology findings and were assessed using FreeSurfer. Group differences and interactions with age and exposure factors were evaluated using a generalized least squares model. A separate logistic regression and independent multinomial model were performed to predict each traumatic encephalopathy syndrome (TES) diagnosis, core clinical features and provisional level of certainty for CTE pathology using brain regions of interest. Former college and professional American football players (combined) showed significant cortical thickness and/or volume reductions compared to unexposed asymptomatic controls in the hippocampus, amygdala, entorhinal cortex, parahippocampal gyrus, insula, temporal pole and superior frontal gyrus. Post hoc analyses identified group-level differences between former professional players and unexposed asymptomatic controls in the hippocampus, amygdala, entorhinal cortex, parahippocampal gyrus, insula and superior frontal gyrus. Former college players showed significant volume reductions in the hippocampus, amygdala and superior frontal gyrus compared to the unexposed asymptomatic controls. We did not observe Age × Group interactions for brain morphometric measures. Interactions between morphometry and exposure measures were limited to a single significant positive association between the age of first exposure to organized tackle football and right insular volume. We found no significant relationship between brain morphometric measures and the TES diagnosis core clinical features and provisional level of certainty for CTE pathology outcomes. These findings suggested that MRI morphometrics detect abnormalities in individuals with a history of repetitive head impact exposure that resemble the anatomic distribution of pathological findings from post-mortem CTE studies. The lack of findings associating MRI measures with exposure metrics (except for one significant relationship) or TES diagnosis and core clinical features suggested that brain morphometry must be complemented by other types of measures to characterize individuals with repetitive head impacts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Certification and implementation of the argon triple point in the fluke SPRT calibration laboratory.
- Author
-
Coleman, Michael and Ding, Rong
- Subjects
- *
BOILING-points , *HEAT flux , *ARGON , *CALIBRATION , *COMPARATOR circuits - Abstract
This paper summarizes the project to certify and implement an argon triple point system into the Fluke SPRT calibration laboratory. For more than twenty years Fluke has provided ISO/IEC 17025 accredited SPRT calibration by fixed point over the range of -197 °C to 962 °C. Fixed point cells were used at all points except for -197 °C where a comparator device using the boiling point of liquid nitrogen and a NIST-calibrated capsule SPRT was used in place of the argon triple point. To improve upon this setup the laboratory acquired an argon triple point system, calibrated it, and implemented it into the SPRT calibration process. This paper gives the results of the project including heat flux (immersion) testing, well-to-well temperature uniformity testing, plateau testing, realization temperature verification, interlaboratory comparison results, and the certification uncertainty analysis. A description of the argon triple point system is provided along with methods of dealing with non-ideal results that can occur when measuring temperature in the argon triple point system with metal-sheath SPRTs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Exogenous Metabolic Modulators Improve Response to Carboplatin in Triple-Negative Breast Cancer
- Author
-
Ho, Alyssa N., primary, Kiesel, Violet A., additional, Gates, Claire E., additional, Brosnan, Bennett H., additional, Connelly, Scott P., additional, Glenny, Elaine M., additional, Cozzo, Alyssa J., additional, Hursting, Stephen D., additional, and Coleman, Michael Francis, additional
- Published
- 2024
- Full Text
- View/download PDF
20. Evaluation of a Digital Entomological Surveillance Planning Tool for Malaria Vector Control: Three Country Mixed Methods Pilot Study
- Author
-
Hemingway, Charlotte, primary, Gowelo, Steven, additional, Opiyo, Mercy, additional, Marrenjo, Dulcisaria, additional, Maquina, Mara, additional, Kaunda-Khangamwa, Blessings N., additional, Kayira, Lusungu, additional, Cherkose, Teklu, additional, Hailmichael, Yohannes, additional, Torres, Neusa, additional, Mucavele, Estevao, additional, Mintade, Muanacha, additional, Candrinho, Baltazar, additional, Mzilahowa, Themba, additional, Belachew, Endalamaw Gadisa, additional, Tatarsky, Allison, additional, Vajda, Élodie A., additional, Dantzer, Emily, additional, Thomsen, Edward, additional, Coleman, Michael, additional, and Lobo, Neil F., additional
- Published
- 2024
- Full Text
- View/download PDF
21. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
- Author
-
Woods, Scott W., Parker, Sophie, Kerr, Melissa J., Walsh, Barbara C., Wijtenburg, S. Andrea, Prunier, Nicholas, Nunez, Angela R., Buccilli, Kate, Mourgues-Codern, Catalina, Brummitt, Kali, Kinney, Kyle S., Trankler, Carli, Szacilo, Julia, Colton, Beau-Luke, Ali, Munaza, Haidar, Anastasia, Billah, Tashrif, Huynh, Kevin, Ahmed, Uzair, Adery, Laura L., Marcy, Patricia J., Allott, Kelly, Amminger, Paul, Arango, Celso, Broome, Matthew R., Cadenhead, Kristin S., Chen, Eric Y. H., Choi, Jimmy, Conus, Philippe, Cornblatt, Barbara A., Glenthøj, Louise Birkedal, Horton, Leslie E., Kambeitz, Joseph, Kapur, Tina, Keshavan, Matcheri S., Koutsouleris, Nikolaos, Langbein, Kerstin, Lavoie, Suzie, Diaz-Caneja, Covadonga Martinez, Mathalon, Daniel H., Mittal, Vijay A., Nordentoft, Merete, Pasternak, Ofer, Pearlson, Godfrey D., Gaspar, Pablo A., Shah, Jai L., Smesny, Stefan, Stone, William S., Strauss, Gregory P., Wang, Jijun, Corcoran, Cheryl M., Perkins, Diana O., Schiffman, Jason, Perez, Jesus, Mamah, Daniel, Ellman, Lauren M., Powers III, Albert R., Coleman, Michael J., Anticevic, Alan, Fusar-Poli, Paolo, Kane, John M., Kahn, Rene S., McGorry, Patrick D., Bearden, Carrie E., Shenton, Martha E., Nelson, Barnaby, Calkins, Monica E., Hendricks, Larry, Bouix, Sylvain, Addington, Jean, McGlashan, Thomas H., Yung, Alison R., Woods, Scott W., Parker, Sophie, Kerr, Melissa J., Walsh, Barbara C., Wijtenburg, S. Andrea, Prunier, Nicholas, Nunez, Angela R., Buccilli, Kate, Mourgues-Codern, Catalina, Brummitt, Kali, Kinney, Kyle S., Trankler, Carli, Szacilo, Julia, Colton, Beau-Luke, Ali, Munaza, Haidar, Anastasia, Billah, Tashrif, Huynh, Kevin, Ahmed, Uzair, Adery, Laura L., Marcy, Patricia J., Allott, Kelly, Amminger, Paul, Arango, Celso, Broome, Matthew R., Cadenhead, Kristin S., Chen, Eric Y. H., Choi, Jimmy, Conus, Philippe, Cornblatt, Barbara A., Glenthøj, Louise Birkedal, Horton, Leslie E., Kambeitz, Joseph, Kapur, Tina, Keshavan, Matcheri S., Koutsouleris, Nikolaos, Langbein, Kerstin, Lavoie, Suzie, Diaz-Caneja, Covadonga Martinez, Mathalon, Daniel H., Mittal, Vijay A., Nordentoft, Merete, Pasternak, Ofer, Pearlson, Godfrey D., Gaspar, Pablo A., Shah, Jai L., Smesny, Stefan, Stone, William S., Strauss, Gregory P., Wang, Jijun, Corcoran, Cheryl M., Perkins, Diana O., Schiffman, Jason, Perez, Jesus, Mamah, Daniel, Ellman, Lauren M., Powers III, Albert R., Coleman, Michael J., Anticevic, Alan, Fusar-Poli, Paolo, Kane, John M., Kahn, Rene S., McGorry, Patrick D., Bearden, Carrie E., Shenton, Martha E., Nelson, Barnaby, Calkins, Monica E., Hendricks, Larry, Bouix, Sylvain, Addington, Jean, McGlashan, Thomas H., and Yung, Alison R.
- Abstract
Aim To harmonize two ascertainment and severity rating instruments commonly used for the clinical high risk syndrome for psychosis (CHR-P): the Structured Interview for Psychosis-risk Syndromes (SIPS) and the Comprehensive Assessment of At-Risk Mental States (CAARMS). Methods The initial workshop is described in the companion report from Addington et al. After the workshop, lead experts for each instrument continued harmonizing attenuated positive symptoms and criteria for psychosis and CHR-P through an intensive series of joint videoconferences. Results Full harmonization was achieved for attenuated positive symptom ratings and psychosis criteria, and modest harmonization for CHR-P criteria. The semi-structured interview, named Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS (PSYCHS), generates CHR-P criteria and severity scores for both CAARMS and SIPS. Conclusions Using the PSYCHS for CHR-P ascertainment, conversion determination, and attenuated positive symptom severity rating will help in comparing findings across studies and in meta-analyses.
- Published
- 2024
22. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ):Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
- Author
-
Wannan, Cassandra M.J., Nelson, Barnaby, Addington, Jean, Allott, Kelly, Anticevic, Alan, Arango, Celso, Baker, Justin T., Bearden, Carrie E., Billah, Tashrif, Bouix, Sylvain, Broome, Matthew R., Buccilli, Kate, Cadenhead, Kristin S., Calkins, Monica E., Cannon, Tyrone D., Cecci, Guillermo, Chen, Eric Yu Hai, Cho, Kang Ik K., Choi, Jimmy, Clark, Scott R., Coleman, Michael J., Conus, Philippe, Corcoran, Cheryl M., Cornblatt, Barbara A., Diaz-Caneja, Covadonga M., Dwyer, Dominic, Ebdrup, Bjørn H., Ellman, Lauren M., Fusar-Poli, Paolo, Galindo, Liliana, Gaspar, Pablo A., Gerber, Carla, Glenthøj, Louise Birkedal, Glynn, Robert, Harms, Michael P., Horton, Leslie E., Kahn, René S., Kambeitz, Joseph, Kambeitz-Ilankovic, Lana, Kane, John M., Kapur, Tina, Keshavan, Matcheri S., Kim, Sung Wan, Koutsouleris, Nikolaos, Kubicki, Marek, Kwon, Jun Soo, Langbein, Kerstin, Lewandowski, Kathryn E., Light, Gregory A., Mamah, Daniel, Marcy, Patricia J., Mathalon, Daniel H., McGorry, Patrick D., Mittal, Vijay A., Nordentoft, Merete, Nunez, Angela, Pasternak, Ofer, Pearlson, Godfrey D., Perez, Jesus, Perkins, Diana O., Powers, Albert R., Roalf, David R., Sabb, Fred W., Schiffman, Jason, Shah, Jai L., Smesny, Stefan, Spark, Jessica, Stone, William S., Strauss, Gregory P., Tamayo, Zailyn, Torous, John, Upthegrove, Rachel, Vangel, Mark, Verma, Swapna, Wang, Jijun, Rossum, Inge Winter van, Wolf, Daniel H., Wolff, Phillip, Wood, Stephen J., Yung, Alison R., Agurto, Carla, Alvarez-Jimenez, Mario, Amminger, Paul, Armando, Marco, Asgari-Targhi, Ameneh, Cahill, John, Carrión, Ricardo E., Castro, Eduardo, Cetin-Karayumak, Suheyla, Mallar Chakravarty, M., Cho, Youngsun T., Cotter, David, D'Alfonso, Simon, Ennis, Michaela, Fadnavis, Shreyas, Fonteneau, Clara, Gao, Caroline, Gupta, Tina, Gur, Raquel E., Gur, Ruben C., Hamilton, Holly K., Hoftman, Gil D., Jacobs, Grace R., Jarcho, Johanna, Ji, Jie Lisa, Kohler, Christian G., Lalousis, Paris Alexandros, Lavoie, Suzie, Lepage, Martin, Liebenthal, Einat, Mervis, Josh, Murty, Vishnu, Nicholas, Spero C., Ning, Lipeng, Penzel, Nora, Poldrack, Russell, Polosecki, Pablo, Pratt, Danielle N., Rabin, Rachel, Rahimi Eichi, Habiballah, Rathi, Yogesh, Reichenberg, Avraham, Reinen, Jenna, Rogers, Jack, Ruiz-Yu, Bernalyn, Scott, Isabelle, Seitz-Holland, Johanna, Srihari, Vinod H., Srivastava, Agrima, Thompson, Andrew, Turetsky, Bruce I., Walsh, Barbara C., Whitford, Thomas, Wigman, Johanna T.W., Yao, Beier, Yuen, Hok Pan, Ahmed, Uzair, Byun, Andrew Jin Soo, Chung, Yoonho, Do, Kim, Hendricks, Larry, Huynh, Kevin, Jeffries, Clark, Lane, Erlend, Langholm, Carsten, Lin, Eric, Mantua, Valentina, Santorelli, Gennarina, Ruparel, Kosha, Zoupou, Eirini, Adasme, Tatiana, Addamo, Lauren, Adery, Laura, Ali, Munaza, Auther, Andrea, Aversa, Samantha, Baek, Seon Hwa, Bates, Kelly, Bathery, Alyssa, Bayer, Johanna M.M., Beedham, Rebecca, Bilgrami, Zarina, Birch, Sonia, Bonoldi, Ilaria, Borders, Owen, Borgatti, Renato, Brown, Lisa, Bruna, Alejandro, Carrington, Holly, Castillo-Passi, Rolando I., Chen, Justine, Cheng, Nicholas, Ching, Ann Ee, Clifford, Chloe, Colton, Beau Luke, Contreras, Pamela, Corral, Sebastián, Damiani, Stefano, Done, Monica, Estradé, Andrés, Etuka, Brandon Asika, Formica, Melanie, Furlan, Rachel, Geljic, Mia, Germano, Carmela, Getachew, Ruth, Goncalves, Mathias, Haidar, Anastasia, Hartmann, Jessica, Jo, Anna, John, Omar, Kerins, Sarah, Kerr, Melissa, Kesselring, Irena, Kim, Honey, Kim, Nicholas, Kinney, Kyle, Krcmar, Marija, Kotler, Elana, Lafanechere, Melanie, Lee, Clarice, Llerena, Joshua, Markiewicz, Christopher, Matnejl, Priya, Maturana, Alejandro, Mavambu, Aissata, Mayol-Troncoso, Rocío, McDonnell, Amelia, McGowan, Alessia, McLaughlin, Danielle, McIlhenny, Rebecca, McQueen, Brittany, Mebrahtu, Yohannes, Mensi, Martina, Hui, Christy Lai Ming, Suen, Yi Nam, Wong, Stephanie Ming Yin, Morrell, Neal, Omar, Mariam, Partridge, Alice, Phassouliotis, Christina, Pichiecchio, Anna, Politi, Pierluigi, Porter, Christian, Provenzani, Umberto, Prunier, Nicholas, Raj, Jasmine, Ray, Susan, Rayner, Victoria, Reyes, Manuel, Reynolds, Kate, Rush, Sage, Salinas, Cesar, Shetty, Jashmina, Snowball, Callum, Tod, Sophie, Turra-Fariña, Gabriel, Valle, Daniela, Veale, Simone, Whitson, Sarah, Wickham, Alana, Youn, Sarah, Zamorano, Francisco, Zavaglia, Elissa, Zinberg, Jamie, Woods, Scott W., Shenton, Martha E., Wannan, Cassandra M.J., Nelson, Barnaby, Addington, Jean, Allott, Kelly, Anticevic, Alan, Arango, Celso, Baker, Justin T., Bearden, Carrie E., Billah, Tashrif, Bouix, Sylvain, Broome, Matthew R., Buccilli, Kate, Cadenhead, Kristin S., Calkins, Monica E., Cannon, Tyrone D., Cecci, Guillermo, Chen, Eric Yu Hai, Cho, Kang Ik K., Choi, Jimmy, Clark, Scott R., Coleman, Michael J., Conus, Philippe, Corcoran, Cheryl M., Cornblatt, Barbara A., Diaz-Caneja, Covadonga M., Dwyer, Dominic, Ebdrup, Bjørn H., Ellman, Lauren M., Fusar-Poli, Paolo, Galindo, Liliana, Gaspar, Pablo A., Gerber, Carla, Glenthøj, Louise Birkedal, Glynn, Robert, Harms, Michael P., Horton, Leslie E., Kahn, René S., Kambeitz, Joseph, Kambeitz-Ilankovic, Lana, Kane, John M., Kapur, Tina, Keshavan, Matcheri S., Kim, Sung Wan, Koutsouleris, Nikolaos, Kubicki, Marek, Kwon, Jun Soo, Langbein, Kerstin, Lewandowski, Kathryn E., Light, Gregory A., Mamah, Daniel, Marcy, Patricia J., Mathalon, Daniel H., McGorry, Patrick D., Mittal, Vijay A., Nordentoft, Merete, Nunez, Angela, Pasternak, Ofer, Pearlson, Godfrey D., Perez, Jesus, Perkins, Diana O., Powers, Albert R., Roalf, David R., Sabb, Fred W., Schiffman, Jason, Shah, Jai L., Smesny, Stefan, Spark, Jessica, Stone, William S., Strauss, Gregory P., Tamayo, Zailyn, Torous, John, Upthegrove, Rachel, Vangel, Mark, Verma, Swapna, Wang, Jijun, Rossum, Inge Winter van, Wolf, Daniel H., Wolff, Phillip, Wood, Stephen J., Yung, Alison R., Agurto, Carla, Alvarez-Jimenez, Mario, Amminger, Paul, Armando, Marco, Asgari-Targhi, Ameneh, Cahill, John, Carrión, Ricardo E., Castro, Eduardo, Cetin-Karayumak, Suheyla, Mallar Chakravarty, M., Cho, Youngsun T., Cotter, David, D'Alfonso, Simon, Ennis, Michaela, Fadnavis, Shreyas, Fonteneau, Clara, Gao, Caroline, Gupta, Tina, Gur, Raquel E., Gur, Ruben C., Hamilton, Holly K., Hoftman, Gil D., Jacobs, Grace R., Jarcho, Johanna, Ji, Jie Lisa, Kohler, Christian G., Lalousis, Paris Alexandros, Lavoie, Suzie, Lepage, Martin, Liebenthal, Einat, Mervis, Josh, Murty, Vishnu, Nicholas, Spero C., Ning, Lipeng, Penzel, Nora, Poldrack, Russell, Polosecki, Pablo, Pratt, Danielle N., Rabin, Rachel, Rahimi Eichi, Habiballah, Rathi, Yogesh, Reichenberg, Avraham, Reinen, Jenna, Rogers, Jack, Ruiz-Yu, Bernalyn, Scott, Isabelle, Seitz-Holland, Johanna, Srihari, Vinod H., Srivastava, Agrima, Thompson, Andrew, Turetsky, Bruce I., Walsh, Barbara C., Whitford, Thomas, Wigman, Johanna T.W., Yao, Beier, Yuen, Hok Pan, Ahmed, Uzair, Byun, Andrew Jin Soo, Chung, Yoonho, Do, Kim, Hendricks, Larry, Huynh, Kevin, Jeffries, Clark, Lane, Erlend, Langholm, Carsten, Lin, Eric, Mantua, Valentina, Santorelli, Gennarina, Ruparel, Kosha, Zoupou, Eirini, Adasme, Tatiana, Addamo, Lauren, Adery, Laura, Ali, Munaza, Auther, Andrea, Aversa, Samantha, Baek, Seon Hwa, Bates, Kelly, Bathery, Alyssa, Bayer, Johanna M.M., Beedham, Rebecca, Bilgrami, Zarina, Birch, Sonia, Bonoldi, Ilaria, Borders, Owen, Borgatti, Renato, Brown, Lisa, Bruna, Alejandro, Carrington, Holly, Castillo-Passi, Rolando I., Chen, Justine, Cheng, Nicholas, Ching, Ann Ee, Clifford, Chloe, Colton, Beau Luke, Contreras, Pamela, Corral, Sebastián, Damiani, Stefano, Done, Monica, Estradé, Andrés, Etuka, Brandon Asika, Formica, Melanie, Furlan, Rachel, Geljic, Mia, Germano, Carmela, Getachew, Ruth, Goncalves, Mathias, Haidar, Anastasia, Hartmann, Jessica, Jo, Anna, John, Omar, Kerins, Sarah, Kerr, Melissa, Kesselring, Irena, Kim, Honey, Kim, Nicholas, Kinney, Kyle, Krcmar, Marija, Kotler, Elana, Lafanechere, Melanie, Lee, Clarice, Llerena, Joshua, Markiewicz, Christopher, Matnejl, Priya, Maturana, Alejandro, Mavambu, Aissata, Mayol-Troncoso, Rocío, McDonnell, Amelia, McGowan, Alessia, McLaughlin, Danielle, McIlhenny, Rebecca, McQueen, Brittany, Mebrahtu, Yohannes, Mensi, Martina, Hui, Christy Lai Ming, Suen, Yi Nam, Wong, Stephanie Ming Yin, Morrell, Neal, Omar, Mariam, Partridge, Alice, Phassouliotis, Christina, Pichiecchio, Anna, Politi, Pierluigi, Porter, Christian, Provenzani, Umberto, Prunier, Nicholas, Raj, Jasmine, Ray, Susan, Rayner, Victoria, Reyes, Manuel, Reynolds, Kate, Rush, Sage, Salinas, Cesar, Shetty, Jashmina, Snowball, Callum, Tod, Sophie, Turra-Fariña, Gabriel, Valle, Daniela, Veale, Simone, Whitson, Sarah, Wickham, Alana, Youn, Sarah, Zamorano, Francisco, Zavaglia, Elissa, Zinberg, Jamie, Woods, Scott W., and Shenton, Martha E.
- Abstract
This article describes the rationale, aims, and methodology of the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). This is the largest international collaboration to date that will develop algorithms to predict trajectories and outcomes of individuals at clinical high risk (CHR) for psychosis and to advance the development and use of novel pharmacological interventions for CHR individuals. We present a description of the participating research networks and the data processing analysis and coordination center, their processes for data harmonization across 43 sites from 13 participating countries (recruitment across North America, Australia, Europe, Asia, and South America), data flow and quality assessment processes, data analyses, and the transfer of data to the National Institute of Mental Health (NIMH) Data Archive (NDA) for use by the research community. In an expected sample of approximately 2000 CHR individuals and 640 matched healthy controls, AMP SCZ will collect clinical, environmental, and cognitive data along with multimodal biomarkers, including neuroimaging, electrophysiology, fluid biospecimens, speech and facial expression samples, novel measures derived from digital health technologies including smartphone-based daily surveys, and passive sensing as well as actigraphy. The study will investigate a range of clinical outcomes over a 2-year period, including transition to psychosis, remission or persistence of CHR status, attenuated positive symptoms, persistent negative symptoms, mood and anxiety symptoms, and psychosocial functioning. The global reach of AMP SCZ and its harmonized innovative methods promise to catalyze the development of new treatments to address critical unmet clinical and public health needs in CHR individuals., This article describes the rationale, aims, and methodology of the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). This is the largest international collaboration to date that will develop algorithms to predict trajectories and outcomes of individuals at clinical high risk (CHR) for psychosis and to advance the development and use of novel pharmacological interventions for CHR individuals. We present a description of the participating research networks and the data processing analysis and coordination center, their processes for data harmonization across 43 sites from 13 participating countries (recruitment across North America, Australia, Europe, Asia, and South America), data flow and quality assessment processes, data analyses, and the transfer of data to the National Institute of Mental Health (NIMH) Data Archive (NDA) for use by the research community. In an expected sample of approximately 2000 CHR individuals and 640 matched healthy controls, AMP SCZ will collect clinical, environmental, and cognitive data along with multimodal biomarkers, including neuroimaging, electrophysiology, fluid biospecimens, speech and facial expression samples, novel measures derived from digital health technologies including smartphone-based daily surveys, and passive sensing as well as actigraphy. The study will investigate a range of clinical outcomes over a 2-year period, including transition to psychosis, remission or persistence of CHR status, attenuated positive symptoms, persistent negative symptoms, mood and anxiety symptoms, and psychosocial functioning. The global reach of AMP SCZ and its harmonized innovative methods promise to catalyze the development of new treatments to address critical unmet clinical and public health needs in CHR individuals.
- Published
- 2024
23. Development of the PSYCHS:Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
- Author
-
Woods, Scott W., Parker, Sophie, Kerr, Melissa J., Walsh, Barbara C., Wijtenburg, S. Andrea, Prunier, Nicholas, Nunez, Angela R., Buccilli, Kate, Mourgues-Codern, Catalina, Brummitt, Kali, Kinney, Kyle S., Trankler, Carli, Szacilo, Julia, Colton, Beau Luke, Ali, Munaza, Haidar, Anastasia, Billah, Tashrif, Huynh, Kevin, Ahmed, Uzair, Adery, Laura L., Marcy, Patricia J., Allott, Kelly, Amminger, Paul, Arango, Celso, Broome, Matthew R., Cadenhead, Kristin S., Chen, Eric Y. H., Choi, Jimmy, Conus, Philippe, Cornblatt, Barbara A., Glenthøj, Louise Birkedal, Horton, Leslie E., Kambeitz, Joseph, Kapur, Tina, Keshavan, Matcheri S., Koutsouleris, Nikolaos, Langbein, Kerstin, Lavoie, Suzie, Diaz-Caneja, Covadonga Martinez, Mathalon, Daniel H, Mittal, Vijay A., Nordentoft, Merete, Pasternak, Ofer, Pearlson, Godfrey D, Gaspar, Pablo A., Shah, Jai L., Smesny, Stefan, Stone, William S., Strauss, Gregory P., Wang, Jijun, Corcoran, Cheryl M., Perkins, Diana O., Schiffman, Jason, Perez, Jesus, Mamah, Daniel, Ellman, Lauren M., Powers, Albert R., Coleman, Michael J., Anticevic, Alan, Fusar-Poli, Paolo, Kane, John M., Kahn, Rene S., McGorry, Patrick D., Bearden, Carrie E, Shenton, Martha E., Nelson, Barnaby, Calkins, Monica E., Hendricks, Larry, Bouix, Sylvain, Addington, Jean, McGlashan, Thomas H, Yung, Alison R., Woods, Scott W., Parker, Sophie, Kerr, Melissa J., Walsh, Barbara C., Wijtenburg, S. Andrea, Prunier, Nicholas, Nunez, Angela R., Buccilli, Kate, Mourgues-Codern, Catalina, Brummitt, Kali, Kinney, Kyle S., Trankler, Carli, Szacilo, Julia, Colton, Beau Luke, Ali, Munaza, Haidar, Anastasia, Billah, Tashrif, Huynh, Kevin, Ahmed, Uzair, Adery, Laura L., Marcy, Patricia J., Allott, Kelly, Amminger, Paul, Arango, Celso, Broome, Matthew R., Cadenhead, Kristin S., Chen, Eric Y. H., Choi, Jimmy, Conus, Philippe, Cornblatt, Barbara A., Glenthøj, Louise Birkedal, Horton, Leslie E., Kambeitz, Joseph, Kapur, Tina, Keshavan, Matcheri S., Koutsouleris, Nikolaos, Langbein, Kerstin, Lavoie, Suzie, Diaz-Caneja, Covadonga Martinez, Mathalon, Daniel H, Mittal, Vijay A., Nordentoft, Merete, Pasternak, Ofer, Pearlson, Godfrey D, Gaspar, Pablo A., Shah, Jai L., Smesny, Stefan, Stone, William S., Strauss, Gregory P., Wang, Jijun, Corcoran, Cheryl M., Perkins, Diana O., Schiffman, Jason, Perez, Jesus, Mamah, Daniel, Ellman, Lauren M., Powers, Albert R., Coleman, Michael J., Anticevic, Alan, Fusar-Poli, Paolo, Kane, John M., Kahn, Rene S., McGorry, Patrick D., Bearden, Carrie E, Shenton, Martha E., Nelson, Barnaby, Calkins, Monica E., Hendricks, Larry, Bouix, Sylvain, Addington, Jean, McGlashan, Thomas H, and Yung, Alison R.
- Abstract
Aim: To harmonize two ascertainment and severity rating instruments commonly used for the clinical high risk syndrome for psychosis (CHR-P): the Structured Interview for Psychosis-risk Syndromes (SIPS) and the Comprehensive Assessment of At-Risk Mental States (CAARMS). Methods: The initial workshop is described in the companion report from Addington et al. After the workshop, lead experts for each instrument continued harmonizing attenuated positive symptoms and criteria for psychosis and CHR-P through an intensive series of joint videoconferences. Results: Full harmonization was achieved for attenuated positive symptom ratings and psychosis criteria, and modest harmonization for CHR-P criteria. The semi-structured interview, named Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS (PSYCHS), generates CHR-P criteria and severity scores for both CAARMS and SIPS. Conclusions: Using the PSYCHS for CHR-P ascertainment, conversion determination, and attenuated positive symptom severity rating will help in comparing findings across studies and in meta-analyses.
- Published
- 2024
24. Development and Characterization of Syngeneic Orthotopic Transplant Models of Obesity-Responsive Triple-Negative Breast Cancer in C57BL/6J Mice.
- Author
-
Carson, Meredith S., Rädler, Patrick D., Albright, Jody, VerHague, Melissa, Rezeli, Erika T., Roth, Daniel, French, John E., Perou, Charles M., Hursting, Stephen D., and Coleman, Michael F.
- Subjects
BIOLOGICAL models ,IN vitro studies ,TRANSPLANTATION of organs, tissues, etc. ,DATA analysis ,T-test (Statistics) ,RESEARCH funding ,BREAST tumors ,INTERNAL thoracic artery ,IMMUNE system ,CELLULAR signal transduction ,MANN Whitney U Test ,DESCRIPTIVE statistics ,CELL lines ,MICE ,METABOLITES ,RNA ,ANIMAL experimentation ,GENE expression profiling ,ONE-way analysis of variance ,STATISTICS ,ANALYSIS of variance ,SURVIVAL analysis (Biometry) ,DATA analysis software ,OBESITY ,DISEASE progression ,SEQUENCE analysis - Abstract
Simple Summary: Transplanting cell lines into the mammary fat pad of lean and obese mice is a powerful tool to understand how breast cancer is promoted by obesity. However, for this approach to be effective, well-characterized and appropriate cell lines are needed. Here, we have developed four readily tumorigenic claudin-low triple-negative breast cancer cell lines from tumors arising from C3-TAg transgenic C57BL6 mice (B6TAg). We employ transcriptomic analysis of in vitro and in vivo samples to delineate distinct transcriptomic signatures in each cell line. We demonstrate that tumor progression of the three most distinct cell lines was accelerated by diet-induced obesity. Taken together, our data establish these B6TAg cell lines as potentially potent tools to delineate how obesity promotes triple-negative breast cancer progression. Obesity is an established risk and progression factor for triple-negative breast cancer (TNBC), but preclinical studies to delineate the mechanisms underlying the obesity-TNBC link as well as strategies to break that link are constrained by the lack of tumor models syngeneic to obesity-prone mouse strains. C3(1)/SV40 T-antigen (C3-TAg) transgenic mice on an FVB genetic background develop tumors with molecular and pathologic features that closely resemble human TNBC, but FVB mice are resistant to diet-induced obesity (DIO). Herein, we sought to develop transplantable C3-TAg cell lines syngeneic to C57BL/6 mice, an inbred mouse strain that is sensitive to DIO. We backcrossed FVB-Tg(C3-1-TAg)cJeg/JegJ to C57BL/6 mice for ten generations, and spontaneous tumors from those mice were excised and used to generate four clonal cell lines (B6TAg1.02, B6TAg2.03, B6TAg2.10, and B6TAg2.51). We characterized the growth of the four cell lines in both lean and DIO C57BL/6J female mice and performed transcriptomic profiling. Each cell line was readily tumorigenic and had transcriptional profiles that clustered as claudin-low, yet markedly differed from each other in their rate of tumor progression and transcriptomic signatures for key metabolic, immune, and oncogenic signaling pathways. DIO accelerated tumor growth of orthotopically transplanted B6TAg1.02, B6TAg2.03, and B6TAg2.51 cells. Thus, the B6TAg cell lines described herein offer promising and diverse new models to augment the study of DIO-associated TNBC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Smart Worksheets and Their Positive Impact on a Second-Year Chemical Kinetics Course
- Author
-
Shallcross, Dudley E., primary, Davies-Coleman, Michael T., additional, Lloyd, Chris, additional, Heslop, Bill, additional, Eastman, John, additional, Baldwin, Tony, additional, Thistlethwaite, Iain, additional, and Franklin, Sophie D., additional
- Published
- 2024
- Full Text
- View/download PDF
26. Lowering glucose enhances BACE1 activity and Aβ generation in mouse brain slice cultures
- Author
-
Sheppard, Olivia, primary, Humphrey, Robert, additional, Durrant, Claire S., additional, and Coleman, Michael P., additional
- Published
- 2024
- Full Text
- View/download PDF
27. Chronically low NMNAT2 expression causes sub-lethal SARM1 activation and altered response to nicotinamide riboside in axons
- Author
-
Antoniou, Christina, primary, Loreto, Andrea, additional, Gilley, Jonathan, additional, Merlini, Elisa, additional, Orsomando, Giuseppe, additional, and Coleman, Michael P, additional
- Published
- 2024
- Full Text
- View/download PDF
28. Adaptive changes of farmers to the continued invasion of Senecio madagascariensis Poir. (fireweed) in pasture-based systems
- Author
-
Sindel, Brian, primary, Coleman, Michael, additional, and Reeve, Ian, additional
- Published
- 2024
- Full Text
- View/download PDF
29. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
- Author
-
Wannan, Cassandra M J, primary, Nelson, Barnaby, additional, Addington, Jean, additional, Allott, Kelly, additional, Anticevic, Alan, additional, Arango, Celso, additional, Baker, Justin T, additional, Bearden, Carrie E, additional, Billah, Tashrif, additional, Bouix, Sylvain, additional, Broome, Matthew R, additional, Buccilli, Kate, additional, Cadenhead, Kristin S, additional, Calkins, Monica E, additional, Cannon, Tyrone D, additional, Cecci, Guillermo, additional, Chen, Eric Yu Hai, additional, Cho, Kang Ik K, additional, Choi, Jimmy, additional, Clark, Scott R, additional, Coleman, Michael J, additional, Conus, Philippe, additional, Corcoran, Cheryl M, additional, Cornblatt, Barbara A, additional, Diaz-Caneja, Covadonga M, additional, Dwyer, Dominic, additional, Ebdrup, Bjørn H, additional, Ellman, Lauren M, additional, Fusar-Poli, Paolo, additional, Galindo, Liliana, additional, Gaspar, Pablo A, additional, Gerber, Carla, additional, Glenthøj, Louise Birkedal, additional, Glynn, Robert, additional, Harms, Michael P, additional, Horton, Leslie E, additional, Kahn, René S, additional, Kambeitz, Joseph, additional, Kambeitz-Ilankovic, Lana, additional, Kane, John M, additional, Kapur, Tina, additional, Keshavan, Matcheri S, additional, Kim, Sung-Wan, additional, Koutsouleris, Nikolaos, additional, Kubicki, Marek, additional, Kwon, Jun Soo, additional, Langbein, Kerstin, additional, Lewandowski, Kathryn E, additional, Light, Gregory A, additional, Mamah, Daniel, additional, Marcy, Patricia J, additional, Mathalon, Daniel H, additional, McGorry, Patrick D, additional, Mittal, Vijay A, additional, Nordentoft, Merete, additional, Nunez, Angela, additional, Pasternak, Ofer, additional, Pearlson, Godfrey D, additional, Perez, Jesus, additional, Perkins, Diana O, additional, Powers, Albert R, additional, Roalf, David R, additional, Sabb, Fred W, additional, Schiffman, Jason, additional, Shah, Jai L, additional, Smesny, Stefan, additional, Spark, Jessica, additional, Stone, William S, additional, Strauss, Gregory P, additional, Tamayo, Zailyn, additional, Torous, John, additional, Upthegrove, Rachel, additional, Vangel, Mark, additional, Verma, Swapna, additional, Wang, Jijun, additional, Rossum, Inge Winter-van, additional, Wolf, Daniel H, additional, Wolff, Phillip, additional, Wood, Stephen J, additional, Yung, Alison R, additional, Agurto, Carla, additional, Alvarez-Jimenez, Mario, additional, Amminger, Paul, additional, Armando, Marco, additional, Asgari-Targhi, Ameneh, additional, Cahill, John, additional, Carrión, Ricardo E, additional, Castro, Eduardo, additional, Cetin-Karayumak, Suheyla, additional, Mallar Chakravarty, M, additional, Cho, Youngsun T, additional, Cotter, David, additional, D’Alfonso, Simon, additional, Ennis, Michaela, additional, Fadnavis, Shreyas, additional, Fonteneau, Clara, additional, Gao, Caroline, additional, Gupta, Tina, additional, Gur, Raquel E, additional, Gur, Ruben C, additional, Hamilton, Holly K, additional, Hoftman, Gil D, additional, Jacobs, Grace R, additional, Jarcho, Johanna, additional, Ji, Jie Lisa, additional, Kohler, Christian G, additional, Lalousis, Paris Alexandros, additional, Lavoie, Suzie, additional, Lepage, Martin, additional, Liebenthal, Einat, additional, Mervis, Josh, additional, Murty, Vishnu, additional, Nicholas, Spero C, additional, Ning, Lipeng, additional, Penzel, Nora, additional, Poldrack, Russell, additional, Polosecki, Pablo, additional, Pratt, Danielle N, additional, Rabin, Rachel, additional, Rahimi Eichi, Habiballah, additional, Rathi, Yogesh, additional, Reichenberg, Avraham, additional, Reinen, Jenna, additional, Rogers, Jack, additional, Ruiz-Yu, Bernalyn, additional, Scott, Isabelle, additional, Seitz-Holland, Johanna, additional, Srihari, Vinod H, additional, Srivastava, Agrima, additional, Thompson, Andrew, additional, Turetsky, Bruce I, additional, Walsh, Barbara C, additional, Whitford, Thomas, additional, Wigman, Johanna T W, additional, Yao, Beier, additional, Yuen, Hok Pan, additional, Ahmed, Uzair, additional, Byun, Andrew (Jin Soo), additional, Chung, Yoonho, additional, Do, Kim, additional, Hendricks, Larry, additional, Huynh, Kevin, additional, Jeffries, Clark, additional, Lane, Erlend, additional, Langholm, Carsten, additional, Lin, Eric, additional, Mantua, Valentina, additional, Santorelli, Gennarina, additional, Ruparel, Kosha, additional, Zoupou, Eirini, additional, Adasme, Tatiana, additional, Addamo, Lauren, additional, Adery, Laura, additional, Ali, Munaza, additional, Auther, Andrea, additional, Aversa, Samantha, additional, Baek, Seon-Hwa, additional, Bates, Kelly, additional, Bathery, Alyssa, additional, Bayer, Johanna M M, additional, Beedham, Rebecca, additional, Bilgrami, Zarina, additional, Birch, Sonia, additional, Bonoldi, Ilaria, additional, Borders, Owen, additional, Borgatti, Renato, additional, Brown, Lisa, additional, Bruna, Alejandro, additional, Carrington, Holly, additional, Castillo-Passi, Rolando I, additional, Chen, Justine, additional, Cheng, Nicholas, additional, Ching, Ann Ee, additional, Clifford, Chloe, additional, Colton, Beau-Luke, additional, Contreras, Pamela, additional, Corral, Sebastián, additional, Damiani, Stefano, additional, Done, Monica, additional, Estradé, Andrés, additional, Etuka, Brandon Asika, additional, Formica, Melanie, additional, Furlan, Rachel, additional, Geljic, Mia, additional, Germano, Carmela, additional, Getachew, Ruth, additional, Goncalves, Mathias, additional, Haidar, Anastasia, additional, Hartmann, Jessica, additional, Jo, Anna, additional, John, Omar, additional, Kerins, Sarah, additional, Kerr, Melissa, additional, Kesselring, Irena, additional, Kim, Honey, additional, Kim, Nicholas, additional, Kinney, Kyle, additional, Krcmar, Marija, additional, Kotler, Elana, additional, Lafanechere, Melanie, additional, Lee, Clarice, additional, Llerena, Joshua, additional, Markiewicz, Christopher, additional, Matnejl, Priya, additional, Maturana, Alejandro, additional, Mavambu, Aissata, additional, Mayol-Troncoso, Rocío, additional, McDonnell, Amelia, additional, McGowan, Alessia, additional, McLaughlin, Danielle, additional, McIlhenny, Rebecca, additional, McQueen, Brittany, additional, Mebrahtu, Yohannes, additional, Mensi, Martina, additional, Hui, Christy Lai Ming, additional, Suen, Yi Nam, additional, Wong, Stephanie Ming Yin, additional, Morrell, Neal, additional, Omar, Mariam, additional, Partridge, Alice, additional, Phassouliotis, Christina, additional, Pichiecchio, Anna, additional, Politi, Pierluigi, additional, Porter, Christian, additional, Provenzani, Umberto, additional, Prunier, Nicholas, additional, Raj, Jasmine, additional, Ray, Susan, additional, Rayner, Victoria, additional, Reyes, Manuel, additional, Reynolds, Kate, additional, Rush, Sage, additional, Salinas, Cesar, additional, Shetty, Jashmina, additional, Snowball, Callum, additional, Tod, Sophie, additional, Turra-Fariña, Gabriel, additional, Valle, Daniela, additional, Veale, Simone, additional, Whitson, Sarah, additional, Wickham, Alana, additional, Youn, Sarah, additional, Zamorano, Francisco, additional, Zavaglia, Elissa, additional, Zinberg, Jamie, additional, Woods, Scott W, additional, and Shenton, Martha E, additional
- Published
- 2024
- Full Text
- View/download PDF
30. Adaptation of a Commercial NAD+ Quantification Kit to Assay the Base-Exchange Activity and Substrate Preferences of SARM1
- Author
-
Cirilli, Ilenia, primary, Amici, Adolfo, additional, Gilley, Jonathan, additional, Coleman, Michael P., additional, and Orsomando, Giuseppe, additional
- Published
- 2024
- Full Text
- View/download PDF
31. Imperatives for integrated weed management in vegetable production: Evaluating research and adoption
- Author
-
Coleman, Michael J., primary, Kristiansen, Paul, additional, Sindel, Brian M., additional, and Fyfe, Christine, additional
- Published
- 2024
- Full Text
- View/download PDF
32. Editorial Letter, Issue 4.2
- Author
-
Catherwood-Ginn, Jon, primary, Stephens, Brad, additional, Nagle, Lara, additional, Ramirez, Nikki, additional, and Coleman, Michael, additional
- Published
- 2024
- Full Text
- View/download PDF
33. Innovation in Two Contrasting Value Chains: Constraints and Opportunities for Adopting Upland Crop Production in the Vietnamese Mekong Delta
- Author
-
Sang, Le Thanh, primary, Mao Huynh, Nhu, additional, Kristiansen, Paul, additional, and Coleman, Michael, additional
- Published
- 2024
- Full Text
- View/download PDF
34. The Impact of Indoor Residual Spraying on Sandfly Abundance and Incidence of Visceral Leishmaniasis in India from 2016 to 2022
- Author
-
Coffeng, Luc E., primary, De Vlas, Sake J, additional, Singh, Rudra Pratap, additional, James, Ananthu, additional, Bindroo, Joy, additional, Sharma, Niteen K., additional, Ali, Asgar, additional, Singh, Chandramani, additional, Sharma, Sadhana, additional, and Coleman, Michael, additional
- Published
- 2024
- Full Text
- View/download PDF
35. Adaptation of a Commercial NAD + Quantification Kit to Assay the Base-Exchange Activity and Substrate Preferences of SARM1.
- Author
-
Cirilli, Ilenia, Amici, Adolfo, Gilley, Jonathan, Coleman, Michael P., and Orsomando, Giuseppe
- Subjects
ION exchange (Chemistry) ,NAD (Coenzyme) ,BINDING site assay ,ADENINE ,ISOQUINOLINE ,NICOTINAMIDE - Abstract
Here, we report an adapted protocol using the Promega NAD/NADH-Glo™ Assay kit. The assay normally allows quantification of trace amounts of both oxidized and reduced forms of nicotinamide adenine dinucleotide (NAD) by enzymatic cycling, but we now show that the NAD analog 3-acetylpyridine adenine dinucleotide (AcPyrAD) also acts as a substrate for this enzyme-cycling assay. In fact, AcPyrAD generates amplification signals of a larger amplitude than those obtained with NAD. We exploited this finding to devise and validate a novel method for assaying the base-exchange activity of SARM1 in reactions containing NAD and an excess of the free base 3-acetylpyridine (AcPyr), where the product is AcPyrAD. We then used this assay to study competition between AcPyr and other free bases to rank the preference of SARM1 for different base-exchange substrates, identifying isoquinoline as a highly effect substrate that completely outcompetes even AcPyr. This has significant advantages over traditional HPLC methods for assaying SARM1 base exchange as it is rapid, sensitive, cost-effective, and easily scalable. This could represent a useful tool given current interest in the role of SARM1 base exchange in programmed axon death and related human disorders. It may also be applicable to other multifunctional NAD glycohydrolases (EC 3.2.2.6) that possess similar base-exchange activity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport.
- Author
-
Yang, Sen, Niou, Zhen-Xian, Enriquez, Andrea, LaMar, Jacob, Huang, Jui-Yen, Ling, Karen, Jafar-Nejad, Paymaan, Gilley, Jonathan, Coleman, Michael P., Tennessen, Jason M., Rangaraju, Vidhya, and Lu, Hui-Chen
- Subjects
AXONAL transport ,OPTICAL imaging sensors ,GLYCOLYSIS ,ALZHEIMER'S disease ,HUNTINGTON disease ,MOLECULAR biology - Abstract
Background: Bioenergetic maladaptations and axonopathy are often found in the early stages of neurodegeneration. Nicotinamide adenine dinucleotide (NAD), an essential cofactor for energy metabolism, is mainly synthesized by Nicotinamide mononucleotide adenylyl transferase 2 (NMNAT2) in CNS neurons. NMNAT2 mRNA levels are reduced in the brains of Alzheimer's, Parkinson's, and Huntington's disease. Here we addressed whether NMNAT2 is required for axonal health of cortical glutamatergic neurons, whose long-projecting axons are often vulnerable in neurodegenerative conditions. We also tested if NMNAT2 maintains axonal health by ensuring axonal ATP levels for axonal transport, critical for axonal function. Methods: We generated mouse and cultured neuron models to determine the impact of NMNAT2 loss from cortical glutamatergic neurons on axonal transport, energetic metabolism, and morphological integrity. In addition, we determined if exogenous NAD supplementation or inhibiting a NAD hydrolase, sterile alpha and TIR motif-containing protein 1 (SARM1), prevented axonal deficits caused by NMNAT2 loss. This study used a combination of techniques, including genetics, molecular biology, immunohistochemistry, biochemistry, fluorescent time-lapse imaging, live imaging with optical sensors, and anti-sense oligos. Results: We provide in vivo evidence that NMNAT2 in glutamatergic neurons is required for axonal survival. Using in vivo and in vitro studies, we demonstrate that NMNAT2 maintains the NAD-redox potential to provide "on-board" ATP via glycolysis to vesicular cargos in distal axons. Exogenous NAD
+ supplementation to NMNAT2 KO neurons restores glycolysis and resumes fast axonal transport. Finally, we demonstrate both in vitro and in vivo that reducing the activity of SARM1, an NAD degradation enzyme, can reduce axonal transport deficits and suppress axon degeneration in NMNAT2 KO neurons. Conclusion: NMNAT2 ensures axonal health by maintaining NAD redox potential in distal axons to ensure efficient vesicular glycolysis required for fast axonal transport. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
37. Association of Vascular Risk Factors and CSF and Imaging Biomarkers With White Matter Hyperintensities in Former American Football Players.
- Author
-
Ly, Monica T., Tuz-Zahra, Fatima, Tripodis, Yorghos, Adler, Charles H., Balcer, Laura J., Bernick, Charles, Zetterberg, Henrik, Blennow, Kaj, Peskind, Elaine R., Au, Rhoda, Banks, Sarah J., Barr, William B., Wethe, Jennifer V., Bondi, Mark W., Delano-Wood, Lisa M., Cantu, Robert C., Coleman, Michael J., Dodick, David W., McClean, Michael D., and Mez, Jesse B.
- Published
- 2024
- Full Text
- View/download PDF
38. INTEGRITY MATTERS: What constitutes ethical O&P business practices in 2024?
- Author
-
COLEMAN, MICHAEL
- Subjects
BUSINESS ethics ,CHIEF compliance officers ,ETHICS & compliance officers ,MEDICAL personnel ,TECHNOLOGICAL innovations - Published
- 2024
39. Repetitive Head Impacts and Perivascular Space Volume in Former American Football Players.
- Author
-
Jung, Leonard B., Wiegand, Tim L. T., Tuz-Zahra, Fatima, Tripodis, Yorghos, Iliff, Jeffrey J., Piantino, Juan, Arciniega, Hector, Kim, Cara L., Pankatz, Lara, Bouix, Sylvain, Lin, Alexander P., Alosco, Michael L., Daneshvar, Daniel H., Mez, Jesse, Sepehrband, Farshid, Rathi, Yogesh, Pasternak, Ofer, Coleman, Michael J., Adler, Charles H., and Bernick, Charles
- Published
- 2024
- Full Text
- View/download PDF
40. 0579 Electrode Configuration Effect on Usage and Self-Titration
- Author
-
Patel, Ruchir, Lundeen, Max, Byrd, Israel, Lee, Kent, and Coleman, Michael
- Published
- 2024
- Full Text
- View/download PDF
41. Basic implications on three pathways associated with SARS-CoV-2
- Author
-
Lee, Jong hoon, Sergi, Consolato, Kast, Richard E., Kanwar, Badar A., Bourbeau, Jean, Oh, Sangsuk, Sohn, Mun-Gi, Lee, Chul Joong, and Coleman, Michael D.
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts between the host and virus and govern induction, resulting in multiorgan impacts. Its pathophysiology involves the followings: 1) the angiotensin-converting enzyme (ACE2) and Toll-like receptor (TLR) pathways: 2) the neuropilin (NRP) pathway: 3) the spike protein pathway. Therefore, it is necessary to block the pathological course with modulating innate lymphoid cells against diverse corona variants in the future.
- Published
- 2024
- Full Text
- View/download PDF
42. Brain morphometry in former American football players: findings from the DIAGNOSE CTE research project.
- Author
-
Arciniega H, Baucom ZH, Tuz-Zahra F, Tripodis Y, John O, Carrington H, Kim N, Knyazhanskaya EE, Jung LB, Breedlove K, Wiegand TLT, Daneshvar DH, Rushmore RJ, Billah T, Pasternak O, Coleman MJ, Adler CH, Bernick C, Balcer LJ, Alosco ML, Koerte IK, Lin AP, Cummings JL, Reiman EM, Stern RA, Shenton ME, and Bouix S
- Subjects
- Humans, Male, Middle Aged, Aged, United States, Football injuries, Chronic Traumatic Encephalopathy pathology, Chronic Traumatic Encephalopathy diagnostic imaging, Magnetic Resonance Imaging methods, Brain pathology, Brain diagnostic imaging
- Abstract
Exposure to repetitive head impacts in contact sports is associated with neurodegenerative disorders including chronic traumatic encephalopathy (CTE), which currently can be diagnosed only at post-mortem. American football players are at higher risk of developing CTE given their exposure to repetitive head impacts. One promising approach for diagnosing CTE in vivo is to explore known neuropathological abnormalities at post-mortem in living individuals using structural MRI. MRI brain morphometry was evaluated in 170 male former American football players ages 45-74 years (n = 114 professional; n = 56 college) and 54 same-age unexposed asymptomatic male controls (n = 54, age range 45-74). Cortical thickness and volume of regions of interest were selected based on established CTE pathology findings and were assessed using FreeSurfer. Group differences and interactions with age and exposure factors were evaluated using a generalized least squares model. A separate logistic regression and independent multinomial model were performed to predict each traumatic encephalopathy syndrome (TES) diagnosis, core clinical features and provisional level of certainty for CTE pathology using brain regions of interest. Former college and professional American football players (combined) showed significant cortical thickness and/or volume reductions compared to unexposed asymptomatic controls in the hippocampus, amygdala, entorhinal cortex, parahippocampal gyrus, insula, temporal pole and superior frontal gyrus. Post hoc analyses identified group-level differences between former professional players and unexposed asymptomatic controls in the hippocampus, amygdala, entorhinal cortex, parahippocampal gyrus, insula and superior frontal gyrus. Former college players showed significant volume reductions in the hippocampus, amygdala and superior frontal gyrus compared to the unexposed asymptomatic controls. We did not observe Age × Group interactions for brain morphometric measures. Interactions between morphometry and exposure measures were limited to a single significant positive association between the age of first exposure to organized tackle football and right insular volume. We found no significant relationship between brain morphometric measures and the TES diagnosis core clinical features and provisional level of certainty for CTE pathology outcomes. These findings suggested that MRI morphometrics detect abnormalities in individuals with a history of repetitive head impact exposure that resemble the anatomic distribution of pathological findings from post-mortem CTE studies. The lack of findings associating MRI measures with exposure metrics (except for one significant relationship) or TES diagnosis and core clinical features suggested that brain morphometry must be complemented by other types of measures to characterize individuals with repetitive head impacts., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.)
- Published
- 2024
- Full Text
- View/download PDF
43. Cavum Septum Pellucidum in Former American Football Players: Findings From the DIAGNOSE CTE Research Project.
- Author
-
Arciniega H, Jung LB, Tuz-Zahra F, Tripodis Y, John O, Kim N, Carrington HW, Knyazhanskaya EE, Chamaria A, Breedlove K, Wiegand TLT, Daneshvar D, Billah T, Pasternak O, Coleman MJ, Adler CH, Bernick C, Balcer LJ, Alosco ML, Lin AP, Koerte IK, Cummings JL, Reiman EM, Stern RA, Bouix S, and Shenton ME
- Abstract
Background and Objectives: Exposure to repetitive head impacts (RHI) is linked to the development of chronic traumatic encephalopathy (CTE), which can only be diagnosed at post-mortem. The presence of a cavum septum pellucidum (CSP) is a common finding in post-mortem studies of confirmed CTE and in neuroimaging studies of individuals exposed to RHI. This study examines CSP in living former American football players, investigating its association with RHI exposure, traumatic encephalopathy syndrome (TES) diagnosis, and provisional levels of certainty for CTE pathology., Methods: Data from the DIAGNOSE CTE Research Project were used to compare the presence and ratio of CSP in former American football players (n = 175), consisting of former college (n = 58) and former professional players (n = 117), and asymptomatic unexposed controls without RHI exposure (n = 55). We further evaluated potential associations between CSP measures and cumulative head impact index (CHII) measures (frequency, linear acceleration, and rotational force), a TES diagnosis (yes/no), and a provisional level of certainty for CTE pathology (suggestive, possible, and probable)., Results: Former American football players exhibited a higher CSP presence and ratio than unexposed asymptomatic controls. Among player subgroups, professional players showed a greater CSP ratio than former college players and unexposed asymptomatic controls. Among all football players, CHII rotational forces correlated with an increased CSP ratio. No significant associations were found between CSP measures and diagnosis of TES or provisional levels of certainty for CTE pathology., Discussion: This study confirms previous findings, highlighting a greater prevalence of CSP and a greater CSP ratio in former American football players compared with unexposed asymptomatic controls. In addition, former professional players showed a greater CSP ratio than college players. Moreover, the relationship between estimates of CHII rotational forces and CSP measures suggests that cumulative frequency and strength of rotational forces experienced in football are associated with CSP. However, CSP does not directly correlate with TES diagnosis or provisional levels of certainty for CTE, indicating that it may be a consequence of RHI associated with rotational forces. Further research, especially longitudinal studies, is needed for confirmation and to explore changes over time., Competing Interests: C.H. Adler consulted for Avion, CND Life Sciences, Jazz, and PreCon Health; LJB is Editor-in-Chief of the Journal of Neuro-Ophthalmology and is a paid consultant to Biogen (Cambridge, MA, USA); C. Bernick receives research support from the Ultimate Fighting Championship, Top Rank promotions, Haymon Boxing, Las Vegas Raiders, and Professional Bull Riders. He is a paid consultant for Aurora Concussion Therapy Systems, Inc. (St. Paul, MN); A.P. Lin consulted for Agios, BioMarin, and Moncton MRI. He is a co-founder of BrainSpec, Inc; J.L. Cummings has provided consultation to Acadia, Alkahest, AlphaCognition, AriBio, Avanir, Axsome, Behren Therapeutics, Biogen, Biohaven, Cassava, Cortexyme, Diadem, EIP Pharma, Eisai, GemVax, Genentech, Green Valley, Grifols, Janssen, LSP, Merck, NervGen, Novo Nordisk, Oligomerix, Ono, Otsuka, PRODEO, Prothena, ReMYND, Renew, Resverlogix, Roche, Signant Health, Suven, United Neuroscience, and Unlearn AI pharmaceutical, assessment, and investment companies; E.M. Reiman is a compensated scientific advisor for Alkahest, Alzheon, Aural Analytics, Denali, Green Valley, Retromer Therapeutics, and Vaxxinity and is a cofounder of ALZPath; R.A. Stern is a paid consultant to Biogen (Cambridge, MA, USA) and Lundbeck (Copenhagen, Denmark). He is a member of the Board of Directors of King-Devick Technologies, Inc. (Chicago, IL, USA), and he receives royalties for published neuropsychological tests from Psychological Assessment Resources, Inc. (Lutz, FL, USA). He has been a member of the Medical Science Committee for the National Collegiate Athletic Association Student-Athlete Concussion Injury Litigation; I.K. Koerte receives funding for a collaborative project from Abbott Inc. She receives royalties for book chapters. Her spouse is an employee at Siemens AG and a stockholder of Siemens AG and Siemens Healthineers. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.)
- Published
- 2024
- Full Text
- View/download PDF
44. Simple Climate Models That Can Be Used in Primary, Secondary, and Tertiary Education.
- Author
-
Harrison TG, Davies-Coleman MT, Rivett AC, Khan MAH, Sewry JD, Wajrak M, Barker NM, Furze J, Franklin SD, Sellou L, Shallcross NKR, and Shallcross DE
- Abstract
Climate change is of great concern to all age groups but in particular to children. "Simple" climate models have been in place for a long time and can be used effectively with post-16 students. For younger children, modifications are required, and we describe in this paper the development and use of two such models. The first (the Granny Model) is a pictorial version of the model that has been used extensively with primary and early secondary school aged children (14 and younger). The second is an online version of the simple climate model that can be used without recourse to the underpinning mathematics and science but allows children to experiment with changing variables and how these changes affect the average surface temperature of the Earth., Competing Interests: The authors declare no competing financial interest., (© 2024 The Authors. Published by American Chemical Society and Division of Chemical Education, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
45. An Introduction to the Human Connectome Project for Early Psychosis.
- Author
-
Jacobs GR, Coleman MJ, Lewandowski KE, Pasternak O, Cetin-Karayumak S, Mesholam-Gately RI, Wojcik J, Kennedy L, Knyazhanskaya E, Reid B, Swago S, Lyons MG, Rizzoni E, John O, Carrington H, Kim N, Kotler E, Veale S, Haidar A, Prunier N, Haaf M, Levitt JJ, Seitz-Holland J, Rathi Y, Kubicki M, Keshavan MS, Holt DJ, Seidman LJ, Öngür D, Breier A, Bouix S, and Shenton ME
- Abstract
Background: The time following a recent onset of psychosis is a critical period during which intervention may be maximally effective. Studying individuals in this period also offers an opportunity to investigate putative brain biomarkers of illness prior to the long-term effects of chronicity and medication. The Human Connectome Project for Early Psychosis (HCP-EP) was funded by the National Institutes of Mental Health (NIMH) as an extension of the original Human Connectome Project's approach to understanding the human brain and its structural and functional connections., Design: The HCP-EP data were collected at 3 sites in Massachusetts (Beth Israel Deaconess Medical Center, McLean Hospital, and Massachusetts General Hospital), and one site in Indiana (Indiana University). Brigham and Women's Hospital served as the data coordination center and as an imaging site., Results: The HCP-EP dataset includes high-quality clinical, cognitive, functional, neuroimaging, and blood specimen data acquired from 303 individuals between the ages of 16-35 years old with affective psychosis (n = 75), non-affective psychosis (n = 148), and healthy controls (n = 80). Participants with early psychosis were within 5 years of illness onset (mean duration = 1.9 years, standard deviation = 1.4 years). All data and novel or modified analytic tools developed as part of the study are publicly available to the research community through the NIMH Data Archive (NDA) or GitHub (https://github.com/pnlbwh)., Conclusions: This paper provides an overview of the specific HCP-EP procedures, assessments, and protocols, as well as a brief characterization of the study participants to make it easier for researchers to use this rich dataset. Although we focus here on discussing and comparing affective and non-affective psychosis groups, the HCP-EP dataset also provides sufficient information for investigators to group participants differently., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
46. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.
- Author
-
Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Marcy PJ, Allott K, Amminger P, Arango C, Broome MR, Cadenhead KS, Chen EYH, Choi J, Conus P, Cornblatt BA, Glenthøj LB, Horton LE, Kambeitz J, Kapur T, Keshavan MS, Koutsouleris N, Langbein K, Lavoie S, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pasternak O, Pearlson GD, Gaspar PA, Shah JL, Smesny S, Stone WS, Strauss GP, Wang J, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR 3rd, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, and Yung AR
- Subjects
- Humans, Psychiatric Status Rating Scales, Prodromal Symptoms, Psychotic Disorders diagnosis
- Abstract
Aim: To harmonize two ascertainment and severity rating instruments commonly used for the clinical high risk syndrome for psychosis (CHR-P): the Structured Interview for Psychosis-risk Syndromes (SIPS) and the Comprehensive Assessment of At-Risk Mental States (CAARMS)., Methods: The initial workshop is described in the companion report from Addington et al. After the workshop, lead experts for each instrument continued harmonizing attenuated positive symptoms and criteria for psychosis and CHR-P through an intensive series of joint videoconferences., Results: Full harmonization was achieved for attenuated positive symptom ratings and psychosis criteria, and modest harmonization for CHR-P criteria. The semi-structured interview, named Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS (PSYCHS), generates CHR-P criteria and severity scores for both CAARMS and SIPS., Conclusions: Using the PSYCHS for CHR-P ascertainment, conversion determination, and attenuated positive symptom severity rating will help in comparing findings across studies and in meta-analyses., (© 2023 The Authors. Early Intervention in Psychiatry published by John Wiley & Sons Australia, Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
47. Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project.
- Author
-
Su Y, Protas H, Luo J, Chen K, Alosco ML, Adler CH, Balcer LJ, Bernick C, Au R, Banks SJ, Barr WB, Coleman MJ, Dodick DW, Katz DI, Marek KL, McClean MD, McKee AC, Mez J, Daneshvar DH, Palmisano JN, Peskind ER, Turner RW 2nd, Wethe JV, Rabinovici G, Johnson K, Tripodis Y, Cummings JL, Shenton ME, Stern RA, and Reiman EM
- Subjects
- Male, Humans, Middle Aged, tau Proteins, Positron-Emission Tomography, Chronic Traumatic Encephalopathy diagnostic imaging, Chronic Traumatic Encephalopathy pathology, Football injuries, Brain Injuries, Traumatic complications, Carbolines
- Abstract
Introduction: Tau is a key pathology in chronic traumatic encephalopathy (CTE). Here, we report our findings in tau positron emission tomography (PET) measurements from the DIAGNOSE CTE Research Project., Method: We compare flortaucipir PET measures from 104 former professional players (PRO), 58 former college football players (COL), and 56 same-age men without exposure to repetitive head impacts (RHI) or traumatic brain injury (unexposed [UE]); characterize their associations with RHI exposure; and compare players who did or did not meet diagnostic criteria for traumatic encephalopathy syndrome (TES)., Results: Significantly elevated flortaucipir uptake was observed in former football players (PRO+COL) in prespecified regions (p < 0.05). Association between regional flortaucipir uptake and estimated cumulative head impact exposure was only observed in the superior frontal region in former players over 60 years old. Flortaucipir PET was not able to differentiate TES groups., Discussion: Additional studies are needed to further understand tau pathology in CTE and other individuals with a history of RHI., (© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)
- Published
- 2024
- Full Text
- View/download PDF
48. Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer.
- Author
-
Zhao Z, Wang J, Kong W, Fang Z, Coleman M, Milne G, Burkett WC, Newton MA, Lee D, Deng B, Shen X, Suo H, Sun W, Hursting S, Zhou C, and Bae-Jump VL
- Abstract
Objective: Overweight/obesity is the strongest risk factor for endometrial cancer (EC), and weight management can reduce that risk and improve survival. We aimed to establish the differential abilities of intermittent energy restriction (IER) and low-fat diet (LFD), alone and in combination with paclitaxel, to reverse the procancer effects of high-fat diet (HFD)-induced obesity in a mouse model of EC., Methods: Lkb1
fl/fl p53fl/fl mice were fed high-fat diet (HFD) or LFD to generate obese and lean phenotypes, respectively. Obese mice were maintained on HFD or switched to LFD (HFD-LFD) or IER (HFD-IER). Ten weeks after induction of endometrial tumor, mice in each group received paclitaxel or placebo for 4 weeks. Body and tumor weights; tumoral transcriptomic, metabolomic and oxylipin profiles; and serum metabolic hormones and chemocytokines were assessed., Results: HFD-IER and HFD-LFD, relative to HFD, reduced body weight; reversed obesity-induced alterations in serum insulin, leptin and inflammatory factors; and decreased tumor incidence and mass, often to levels emulating those associated with continuous LFD. Concurrent paclitaxel, versus placebo, enhanced tumor suppression in each group, with greatest benefit in HFD-IER. The diets produced distinct tumoral gene expression and metabolic profiles, with HFD-IER associated with a more favorable (antitumor) metabolic and inflammatory environment., Conclusion: In Lkb1fl/fl p53fl/fl mice, IER is generally more effective than LFD in promoting weight loss, inhibiting obesity-related endometrial tumor growth (particularly in combination with paclitaxel), and reversing detrimental obesity-related metabolic effects. These findings lay the foundation for further investigations of IER as a EC prevention strategy in women with overweight/obesity.- Published
- 2024
- Full Text
- View/download PDF
49. Tirzepatide attenuates mammary tumor progression in diet-induced obese mice.
- Author
-
Glenny EM, Ho AN, Kiesel VA, Chen F, Gates CE, Paules EM, Xu R, Holt CA, Coleman MF, and Hursting SD
- Abstract
We report for the first time an anticancer benefit of tirzepatide-a dual glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist-in a model of obesity and breast cancer in female mice. Long-term tirzepatide treatment induced weight loss, mitigated obesity-driven changes in circulating metabolic hormone levels, and suppressed orthotopic E0771 mammary tumor growth. Relative to tirzepatide, chronic calorie restriction, an established anticancer intervention in preclinical models, promoted even greater weight loss, systemic hormonal regulation, and tumor suppression. We conclude that tirzepatide represents a promising pharmacologic approach for mitigating the procancer effects of obesity. Moreover, strategies promoting greater weight loss than achieved with tirzepatide alone may augment the anticancer benefits of tirzepatide., Competing Interests: Disclosures: The authors have no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.